Expression of Vascular Endothelial Growth Factor and Its Receptors in the Central Nervous System in Amyotrophic Lateral Sclerosis
Authors:
- Stephen B. WhartonSWStephen B. Wharton
- Paul G. IncePIPaul G. Ince
- Claire E LewisCLClaire E Lewis
- Pamela J. ShawPSPamela J. Shaw
Open Access
- 1 January 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 65 (1) , 26-36
Abstract
Vascular endothelial growth factor (VEGF) prolongs survival in the mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis (ALS), whereasKeywords
This publication has 30 references indexed in Scilit:
- Molecular and cellular pathways of neurodegeneration in motor neurone diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2005
- A Mutation in the Vesicle-Trafficking Protein VAPB Causes Late-Onset Spinal Muscular Atrophy and Amyotrophic Lateral SclerosisThe American Journal of Human Genetics, 2004
- UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALSAnnual Review of Neuroscience, 2004
- DNA/RNA Helicase Gene Mutations in a Form of Juvenile Amyotrophic Lateral Sclerosis (ALS4)The American Journal of Human Genetics, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003
- Mutant dynactin in motor neuron diseaseNature Genetics, 2003
- The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosisNature Genetics, 2001
- A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2Nature Genetics, 2001
- Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by HypoxiaJournal of Biological Chemistry, 1995
- Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosisHuman Molecular Genetics, 1994